ADC Therapeutics SA (ADCT)

ADC Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	274.27	278.6	326.44	466.54	439.2	115.55
Cash & Short-Term Investments	274.27	278.6	326.44	466.54	439.2	115.55
Cash Growth	-11.64%	-14.66%	-30.03%	6.23%	280.09%	-16.75%
Accounts Receivable	24.03	25.18	72.97	30.22	-	-
Other Receivables	-	-	-	1.93	1.7	1.36
Receivables	24.03	25.18	72.97	32.14	1.7	1.36
Inventory	16.07	16.18	12.07	11.12	-	-
Prepaid Expenses	18.63	16.33	23.5	15.35	8.16	4.22
Other Current Assets	-	-	-	0.02	1.4	1.48
Total Current Assets	333.01	336.29	434.98	525.18	450.45	122.61
Property, Plant & Equipment	14.91	16.13	10.26	11.23	4.76	6.27
Long-Term Investments	-	1.65	7.61	41.24	47.91	-
Other Intangible Assets	-	-	-	12.95	10.18	8.43
Long-Term Deferred Tax Assets	-	-	37.1	26.05	-	-
Long-Term Deferred Charges	-	-	-	0.63	-	-
Other Long-Term Assets	1.17	0.71	0.9	0.69	0.4	0.37
Total Assets	349.08	354.78	490.86	617.97	513.69	137.68
Accounts Payable	14.37	15.57	12.35	12.08	5.28	3.33
Accrued Expenses	40.07	37.6	51.93	37.77	27.4	14.65
Current Portion of Long-Term Debt	7.22	-	-	13.39	3.63	-
Current Portion of Leases	1.48	1.47	1.1	1.03	1	1.13
Current Income Taxes Payable	-	-	-	3.75	0.15	0.05
Other Current Liabilities	4.54	13.04	16.56	5.92	2.98	0.78
Total Current Liabilities	67.68	67.67	81.94	73.94	40.44	19.94
Long-Term Debt	436.81	416.3	322.07	305.82	34.78	-
Long-Term Leases	8.88	10.18	6.56	6.99	2.47	3.9
Long-Term Unearned Revenue	-	-	-	23.54	23.54	-
Other Long-Term Liabilities	7.65	7.69	0.79	37.95	73.43	-
Total Liabilities	521.03	503.03	411.41	451.88	178.19	26.53
Common Stock	8.23	7.31	7.31	6.45	6.31	4.36
Additional Paid-In Capital	1,282	1,181	1,166	981.83	981.06	549.92
Retained Earnings	-1,463	-1,335	-1,095	-924.89	-694.86	-448.57
Treasury Stock	-0.22	-0.54	-0.68	-0.13	-0	-0.1
Comprehensive Income & Other	0.2	-0.09	1.82	102.83	43	5.54
Shareholders' Equity	-171.95	-148.25	79.45	166.09	335.51	111.16
Total Liabilities & Equity	349.08	354.78	490.86	617.97	513.69	137.68
Total Debt	454.4	427.95	329.73	327.23	41.87	5.03
Net Cash (Debt)	-180.12	-149.35	-3.29	139.32	397.32	110.52
Net Cash Growth	-	-	-	-64.94%	259.50%	-20.38%
Net Cash Per Share	-1.97	-1.83	-0.04	1.82	6.07	2.24
Filing Date Shares Outstanding	96.69	82.53	80.64	76.81	76.72	51.5
Total Common Shares Outstanding	96.69	82.29	80.64	76.81	76.72	10.52
Working Capital	265.33	268.62	353.04	451.25	410.01	102.66
Book Value Per Share	-1.78	-1.80	0.99	2.16	4.37	10.56
Tangible Book Value	-171.95	-148.25	79.45	153.14	325.33	102.72
Tangible Book Value Per Share	-1.78	-1.80	0.99	1.99	4.24	9.76
Machinery	6.83	5.94	4.68	4.15	2.54	2.43
Construction In Progress	-	-	-	-	0.07	-
Leasehold Improvements	4.12	3.95	2.08	2.25	0.75	0.53

Source: S&P Capital IQ. Standard template. Financial Sources.